Industrial Purity Specifications and COA Analysis for 4,7-Dichloroquinoline
- Critical Specifications: Assay ≥99.0%, Melting Point 81-83°C, and strict limits on isomeric impurities.
- Quality Assurance: Comprehensive COA documentation including GC/HPLC data and residual solvent analysis.
- Bulk Supply: Scalable manufacturing processes ensuring consistent industrial purity for pharmaceutical intermediates.
In the pharmaceutical and fine chemical industries, the reliability of raw materials dictates the success of downstream synthesis. 4,7-Dichloroquinoline (CAS 86-98-6) serves as a pivotal building block, particularly as a Chloroquine intermediate and in the production of various antimalarial and antimicrobial agents. For procurement officers and process chemists, understanding the technical nuances of the Certificate of Analysis (COA) is non-negotiable. This document verifies that the industrial purity meets the rigorous standards required for GMP-compliant manufacturing.
Understanding Certificate of Analysis (COA) Parameters
A robust COA provides more than just a pass/fail metric; it offers a fingerprint of the chemical batch. For Dichloroquinoline derivatives, the primary parameter is the assay purity, typically determined via Gas Chromatography (GC) or High-Performance Liquid Chromatography (HPLC). Leading manufacturers target an assay of ≥99.0% to minimize side reactions during nucleophilic substitution steps. However, purity alone is insufficient without controlling specific impurities.
The following table outlines the critical quality attributes expected in a premium industrial grade batch:
| Parameter | Specification | Test Method | Significance |
|---|---|---|---|
| Appearance | White to Pale Brown Powder | Visual | Indicates oxidation or decomposition |
| Assay (GC) | ≥ 99.0% | GC Area Normalization | Ensures stoichiometric accuracy |
| Melting Point | 81-83 °C | DSC or Capillary | Confirms identity and crystallinity |
| Loss on Drying | ≤ 0.5% | Karl Fischer / Oven | Prevents hydrolysis during reaction |
| Related Substances | ≤ 0.5% (Total) | HPLC | Controls isomeric contaminants |
Key Impurity Profiles and Synthesis Route Implications
The synthesis route for this compound typically involves the chlorination of 7-chloro-4-hydroxyquinoline using phosphorus oxychloride (POCl3). While efficient, this process can generate specific byproducts that must be monitored. The most critical impurities include the 4,5-isomer and unreacted hydroxy precursors. Even trace amounts of 7-chloro-4-hydroxyquinoline (≤0.3%) can interfere with subsequent amination reactions, leading to reduced yields in the final active pharmaceutical ingredient (API).
Process chemists must evaluate the impurity profile relative to their specific manufacturing process. For instance, if the downstream step involves high-temperature coupling, volatile impurities might be removed easily. However, for sensitive catalytic reactions, strict control over heavy metals and halogenated byproducts is essential. A comprehensive COA will list these related substances individually rather than grouping them under "unknowns," providing transparency that facilitates risk assessment.
GMP Compliance and Quality Assurance in Bulk Production
Scaling from gram-scale laboratory synthesis to multi-ton production introduces variability. Consistency is the hallmark of a reliable global manufacturer. Quality assurance protocols must extend beyond the final product test to include raw material qualification, in-process controls (IPC), and stability testing. Storage conditions also play a vital role; the material should be kept in a cool, dry place, typically between 2-30°C, to prevent degradation.
When evaluating suppliers for 4,7-Dichloroquinoline, buyers must verify the manufacturer's capacity to maintain these specifications across large batches. NINGBO INNO PHARMCHEM CO.,LTD. operates with a focus on technical excellence, ensuring that every drum shipped matches the quality of the initial sample. With substantial production capacity, we cater to both R&D requirements and large-scale industrial orders, mitigating supply chain risks.
Safety and Handling Specifications
Safety data is an integral part of the technical specification package. This compound is classified as an irritant (GHS07) and hazardous to the aquatic environment (GHS09). Proper Personal Protective Equipment (PPE), including dust masks (N95), eyeshields, and gloves, is mandatory during handling. The flash point is approximately 164 °C, classifying it as a combustible solid rather than a flammable liquid, but standard precautions for organic powders apply.
Furthermore, the solubility profile indicates insolubility in water but high solubility in chloroform (50mg/mL). This property is crucial for process engineers designing extraction or crystallization steps. Understanding the physical constants, such as the density (1.4178 g/cm³) and refractive index (1.6300), aids in process analytical technology (PAT) implementations during continuous manufacturing.
Commercial Considerations and Bulk Procurement
The bulk price of quinoline derivatives is influenced by raw material availability, energy costs, and purification complexity. While laboratory reagents often command high premiums per gram, industrial contracts are structured around metric tons. Buyers should seek partners who offer transparent pricing models linked to purity grades. A 98% grade might suffice for certain agrochemical applications, whereas pharmaceutical synthesis demands the ≥99% specification.
Procurement strategies should also account for lead times and packaging. Industrial quantities are typically supplied in 25kg fiber drums or customized containers lined with polyethylene bags to ensure moisture protection. Requesting a pre-shipment sample for internal validation is a standard best practice. This allows the buyer's quality control team to verify the COA data against their own analytical methods before committing to the full shipment.
Conclusion
In summary, securing high-quality 4,7-Dichloro quinoline requires a deep understanding of technical specifications beyond simple assay percentages. By focusing on impurity profiles, melting point consistency, and robust manufacturing practices, chemical buyers can ensure seamless downstream production. Partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. provides access to reliable supply chains and technically supported products. Whether for antimalarial drug synthesis or novel Quinoline derivative research, prioritizing industrial purity specifications is the foundation of successful chemical manufacturing.